3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenia
Latest Information Update: 12 Dec 2019
At a glance
- Drugs Amifampridine (Primary)
- Indications Lambert-Eaton myasthenic syndrome; Muscle weakness
- Focus Adverse reactions; Expanded access
- 09 Dec 2019 Status changed from recruiting to completed.
- 24 Dec 2013 New trial record